Literature DB >> 34555043

Opioid-free anesthesia compared to opioid anesthesia for lung cancer patients undergoing video-assisted thoracoscopic surgery: A randomized controlled study.

Guangquan An1, Yiwen Zhang2, Nuoya Chen2, Jianfeng Fu2, Bingsha Zhao2, Xuelian Zhao2.   

Abstract

BACKGROUND: Reducing intra-operative opioid consumption benefits patients by decreasing postoperative opioid-related adverse events. We assessed whether opioid-free anesthesia would provide effective analgesia-antinociception monitored by analgesia index in video-assisted thoracoscopic surgery.
METHODS: Patients (ASA Ⅰ-Ⅱ, 18-65 years old, BMI <30 kg m-2) scheduled to undergo video-assisted thoracoscopic surgery under general anesthesia were randomly allocated into two groups to receive opioid-free anesthesia (group OFA) with dexmedetomidine, sevoflurane plus thoracic paravertebral blockade or opioid-based anesthesia (group OA) with remifentanil, sevoflurane, and thoracic paravertebral blockade. The primary outcome variable was pain intensity during the operation, assessed by the depth of analgesia using the pain threshold index with the multifunction combination monitor HXD‑I. Secondary outcomes included depth of sedation monitoring by wavelet index and blood glucose concentration achieved from blood gas.
RESULTS: One hundred patients were randomized; 3 patients were excluded due to discontinued intervention and 97 included in the final analysis. Intraoperative pain threshold index readings were not significantly different between group OFA and group OA from arriving operation room to extubation (P = 0.86), while the brain wavelet index readings in group OFA were notably lower than those in group OA from before general anesthesia induction to recovery of double lungs ventilation (P <0.001). After beginning of operation, the blood glucose levels in group OFA increased compared with baseline blood glucose values (P < 0.001). The recovery time and extubation time in group OFA were significantly longer than those in group OA (P <0.007).
CONCLUSIONS: This study suggested that our OFA regimen achieved equally effective intraoperative pain threshold index compared to OA in video-assisted thoracoscopic surgery. Depth of sedation was significantly deeper and blood glucose levels were higher with OFA. Study's limitations and strict inclusion criteria may limit the external validity of the study, suggesting the need of further randomized trials on the topic. Trial registration: ChiCTR1800019479, Title: "Opioid-free anesthesia in video-assisted thoracoscopic surgery lobectomy".

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34555043      PMCID: PMC8460000          DOI: 10.1371/journal.pone.0257279

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  39 in total

Review 1.  The stress response to trauma and surgery.

Authors:  J P Desborough
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

2.  How can we prevent opioid induced hyperalgesia in surgical patients?

Authors:  D Fletcher; V Martinez
Journal:  Br J Anaesth       Date:  2016-04       Impact factor: 9.166

3.  Perioperative Opioid Administration.

Authors:  Harsha Shanthanna; Karim S Ladha; Henrik Kehlet; Girish P Joshi
Journal:  Anesthesiology       Date:  2021-04-01       Impact factor: 7.892

4.  Opioid-free total intravenous anesthesia with propofol, dexmedetomidine and lidocaine infusions for laparoscopic cholecystectomy: a prospective, randomized, double-blinded study.

Authors:  Mefkur Bakan; Tarik Umutoglu; Ufuk Topuz; Harun Uysal; Mehmet Bayram; Huseyin Kadioglu; Ziya Salihoglu
Journal:  Braz J Anesthesiol       Date:  2014-06-03

5.  Development and validation of a risk score to identify patients at high risk for opioid-related adverse drug events.

Authors:  Harold S Minkowitz; Richard Scranton; Stephen K Gruschkus; Kathy Nipper-Johnson; Laura Menditto; Akash Dandappanavar
Journal:  J Manag Care Spec Pharm       Date:  2014-09

6.  Investigation of opioid use and long-term oncologic outcomes for non-small cell lung cancer patients treated with surgery.

Authors:  Tak Kyu Oh; Jae Hyun Jeon; Jong Mog Lee; Moon Soo Kim; Jee Hee Kim; Hyeyeon Cho; Seong-Eun Kim; Woosik Eom
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

7.  Comparison of pretreatment with dexmedetomidine with midazolam for prevention of etomidate-induced myoclonus and attenuation of stress response at intubation: A randomized controlled study.

Authors:  Swarnendu Dey; Meenakshi Kumar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Jan-Mar

8.  Opioid-free anesthesia for breast cancer surgery: An observational study.

Authors:  Swagata Tripathy; Satyajit Rath; Suresh Agrawal; P Bhaskar Rao; A Panda; T S Mishra; Sukdev Nayak
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Jan-Mar

9.  The effects of different doses of dexmedetomidine on the requirements for propofol for loss of consciousness in patients monitored via the bispectral index: a double-blind, placebo-controlled trial.

Authors:  Yang Gu; Fan Yang; Yonghai Zhang; Junwei Zheng; Jie Wang; Bin Li; Tao Ma; Xiang Cui; Kaimei Lu; Hanxiang Ma
Journal:  BMC Anesthesiol       Date:  2020-04-25       Impact factor: 2.217

View more
  2 in total

1.  The Effect of Opioid-Free Anesthesia on the Quality of Recovery After Gynecological Laparoscopy: A Prospective Randomized Controlled Trial.

Authors:  Hoon Choi; Jae Yen Song; Eun Jee Oh; Min Suk Chae; Sanghyuck Yu; Young Eun Moon
Journal:  J Pain Res       Date:  2022-08-03       Impact factor: 2.832

2.  Opioid-free anesthesia compared to opioid anesthesia for laparoscopic radical colectomy with pain threshold index monitoring: a randomized controlled study.

Authors:  Guangquan An; Guiying Wang; Bingsha Zhao; Xiaoying Zhang; Zhihan Li; Jianfeng Fu; Xuelian Zhao
Journal:  BMC Anesthesiol       Date:  2022-07-29       Impact factor: 2.376

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.